A detailed history of Bruce G. Allen Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 2,945 shares of ABBV stock, worth $592,534. This represents 0.45% of its overall portfolio holdings.

Number of Shares
2,945
Previous 2,901 1.52%
Holding current value
$592,534
Previous $498 Million 16.88%
% of portfolio
0.45%
Previous 0.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $7,208 - $8,770
44 Added 1.52%
2,945 $582 Million
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $23,528 - $27,475
152 Added 5.53%
2,901 $498 Million
Q1 2024

Apr 10, 2024

BUY
$159.82 - $182.1 $38,516 - $43,886
241 Added 9.61%
2,749 $501 Million
Q4 2023

Jan 10, 2024

BUY
$137.6 - $154.97 $345,100 - $388,664
2,508 New
2,508 $389 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.